共 154 条
[1]
Margreiter R(2002)Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation a randomised multicentre study Lancet 359 741-746
[2]
Böttiger Y(1999)Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients Br J Clin Pharmacol 48 445-448
[3]
Brattström C(2001)Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation Nephrol Dial Transplant 16 1905-1909
[4]
Tydén G(2001)Therapeutic drug monitoring for immunosuppressants Clin Chim Acta 313 241-253
[5]
Säwe J(2004)Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients Transplantation 78 1182-1187
[6]
Groth C(2006)Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro Drug Metab Dispos Biol Fate Chem 34 836-847
[7]
Staatz C(1992)Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat Drug Metab Dispos Biol Fate Chem. 20 753-761
[8]
Taylor P(2007)Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics Drug Metab Pharmacokinet 22 328-335
[9]
Tett S(2006)Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro Drug Metab Dispos 34 836-847
[10]
Wong S(2006)Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients Pharmacogenet Genom 16 119-127